Index of All Hepatitis B Articles by Topic ( A to Z)

Pegasys plus Epivir-HBV

New Perspectives in the Treatment of HBeAg-positive and HBeAg-negative Chronic Hepatitis B - 6/01/05

Factors Predicting Response to Pegylated Interferon in HBeAg Positive Chronic Hepatitis B - 4/22/05

Peginterferon Alfa-2a (Pegasys) Versus Peginterferon Alfa-2a Plus Lamivudine Versus Lamivudine In HBeAg Positive Chronic HBV - 4/18/05

Sustained HBsAg Seroconversion in Patients with Chronic HBV Treated with Peginterferon Alfa 2a (Pegasys) - 4/18/05

 Greater HBV Suppression with Lamivudine (Epivir-HBV) +/- Peginterferon Alfa-2a (Pegasys) Does Not Translate into Improved Rates of Sustained HBeAg Seroconversion  - 4/18/05

Combination Therapy with Peginterferon Alfa-2a (Pegasys) Plus Lamivudine Does Not Produce a Better Sustained Response in HBeAg (-) Patients Than Does Pegasys Alone - 11/05/04

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B 09/17/04


 

 

 

 

 






 

 

 

 

 

 

 

 

 

 




























Google


FDA-approved
Monotherapies for HBV

Baraclude
   (entecavir)
 Epivir-HBV
   (lamivudine; 3TC)
 Intron A
   (interferon alfa-2b)
Hepsera
  (adefovir dipivoxil)
Pegasys
  (peginterferon alfa-2a)
Tyzeka
  (telbivudine)

HEPATITIS B
THERAPIES CHART

TOP NEW
HEPATITS B ARTICLES